Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-05 4:02 pm |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
11,333 | $3.283 | $37,206 | 86,244 (Direct) |
View |
| 2021-12-27 Purchase |
2021-12-28 7:04 pm |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
7,000 | $0.59 | $4,130 | 7,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 6:25 pm |
N/A 2035-02-14 |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
274,600 | $0 | 360,844 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:55 pm |
N/A 2034-02-01 |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
475,600 | $0 | 475,600 (Direct) |
View |
| 2023-07-10 Option Award |
2023-07-12 4:12 pm |
N/A 2033-07-10 |
Arbutus Biopharma Corp | ABUS | Naftzger J. Christopher General Counsel and CCO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-08-11 Exercise |
2022-08-15 8:39 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
189,600 | $0 | 94,800 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 6:35 pm |
N/A 2032-01-27 |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
94,800 | $0 | 94,800 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-01 4:06 pm |
N/A 2031-09-29 |
Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec |
100,000 | $0 | 100,000 (Direct) |
View |